Hemington Wealth Management Neogenomics Inc Transaction History
Hemington Wealth Management
- $398 Million
- Q4 2024
A detailed history of Hemington Wealth Management transactions in Neogenomics Inc stock. As of the latest transaction made, Hemington Wealth Management holds 21 shares of NEO stock, worth $282. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 14
50.0%
Holding current value
$282
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$265 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$189 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$92.7 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$88.8 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$88 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.69B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...